Prof. Dr. Robert Soler Rich, MD, PhD

Meet Prof. Dr. Robert Soler Rich, a highly experienced doctor with 42 years of practice specializing in regenerative medicine and orthopedics. He works at the Teknon Medical Centre in Barcelona, Spain, specifically in the Department of Tissue Regeneration Therapy and Stem Cell Therapy. Prof. Dr. Soler Rich has an impressive career background, including his graduation from the Faculty of Medicine and Surgery of the Autonomous University of Barcelona in 1981. He has further honed his expertise through specialized training in sports medicine, biology, and sports traumatology. With his vast knowledge and skills, he has served in renowned medical centers such as the Hotel Dieu University Hospital Centre and Montpelier University Hospital Centre. One of the remarkable aspects of Prof. Dr. Soler Rich's career is his role as the Founder and Co-Director of the Institute of Regenerative Tissue Therapy at Teknon Medical Center. In addition, he has been a faculty member and the Medical Director of the same institute, highlighting his significant contributions to regenerative medicine. To further showcase his dedication to the medical community, Prof. Dr. Soler Rich is a member of various prestigious organizations, including the Spanish Society of Rheumatology, MuscleTech Network, and the Clinical and Experimental Research Group on Veterinary Trauma Medicine and Orthopaedics. These affiliations demonstrate his commitment to staying updated with the latest advancements in his field. Prof. Dr. Soler Rich has actively contributed to the medical literature with eight scientific publications. His research focuses on radiation-induced xerostomia, cellular therapy legislation, and novel therapeutic approaches for diseases like COVID-19. Overall, Prof. Dr. Robert Soler Rich is an exceptional regenerative medicine and orthopedics doctor. With his extensive experience, notable career highlights, and dedication to advancing medical knowledge, he continues to make a significant impact in his profession.